The Change in B-Type Natriuretic Peptide Levels Over Time Predicts Significant Rejection in Cardiac Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 28, Issue 7, 2009, Pages 704-709

  Kittleson, Michelle M ^a   Skojec, Diane V ^b   Wittstein, Ilan S ^b   Champion, Hunter C ^b   Judge, Daniel P ^b   Barouch, Lili A ^b   Halushka, Marc ^b   Hare, Joshua M ^b   Kasper, Edward K ^b   Russell, Stuart D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISONE;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEMODYNAMIC PARAMETERS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PREDICTOR VARIABLE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 67649128516     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.019     Document Type: Article

References (29)

1. Deckers J.W., Hare J.M., and Baughman K.L. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 19 (1992) 43-47
2. Chen H.H., and Burnett J.C. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep 2 (2000) 198-205
3. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
4. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
5. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
6. Rothenburger M., Wichter T., Schmid C., et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 23 (2004) 1189-1197
7. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
8. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
9. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86 (2001) 21-26
10. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., Doughty R.N., and Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf) 47 (1997) 287-296
11. Groenning B.A., Raymond I., Hildebrandt P.R., Nilsson J.C., Baumann M., and Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 90 (2004) 297-303
12. Bay M., Kirk V., Parner J., et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89 (2003) 150-154
13. Kirk V., Bay M., Parner J., et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail 6 (2004) 335-341
14. Hartmann F., Packer M., Coats A.J., et al. NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 6 (2004) 343-350
15. Hammerer-Lercher A., Mair J., Antretter H., et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transplant 24 (2005) 1444
16. Wu A.H., Johnson M.L., Aaronson K.D., Gordon D., Dyke D.B., and Koelling T.M. Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements. J Heart Lung Transplant 24 (2005) 52-57
17. Ogawa T., Veinot J.P., Davies R.A., et al. Neuroendocrine profiling of humans receiving cardiac allografts. J Heart Lung Transplant 24 (2005) 1046-1054
18. Shaw S.M., and Williams S.G. Is brain natriuretic peptide clinically useful after cardiac transplantation?. J Heart Lung Transplant 25 (2006) 1396-1401
19. O'Neill J.O., McRae III A.T., Troughton R.W., et al. Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients. J Heart Lung Transplant 24 (2005) 416-420
20. Lan Y.T., Chang R.K., Alejos J.C., Burch C., and Wetzel G.T. B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 23 (2004) 558-563
21. Arnau-Vives M.A., Almenar L., Hervas I., et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transplant 23 (2004) 850-856
22. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
23. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060
24. Winters G.L., and McManus B.M. Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J Heart Lung Transplant 15 (1996) 728-735
25. Winters G.L., Marboe C.C., and Billingham M.E. The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant 17 (1998) 754-760
26. Nielsen H., Sorensen F.B., Nielsen B., Bagger J.P., Thayssen P., and Baandrup U. Reproducibility of the acute rejection diagnosis in human cardiac allografts. The Stanford Classification and the International Grading System. J Heart Lung Transplant 12 (1993) 239-243
27. Masters R.G., Davies R.A., Veinot J.P., Hendry P.J., Smith S.J., and de Bold A.J. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 100 (1999) 287-291
28. Martinez-Dolz L., Almenar L., Hervas I., et al. Prognostic relationship between two serial determinations of B-type natriuretic peptide and medium-long-term events in heart transplantation. J Heart Lung Transplant 27 (2008) 735-740
29. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160